PLS3 and primary cutaneous T-cell non-Hodgkin lymphoma: For example, in patients with Sezary syndrome, a leukemic and erythrodermic variant of cutaneous T cell lymphomas, upregulation of PLS3 has been observed which is in part due to the hypomethylation of the PLS3 promoter [10,11].